Cetuximab and Chemotherapy for Patients with Unresectable CRC Liver Metastasis: Are We Changing the Natural Course of the Disease?

Publisher： Karger

E-ISSN： 2296-5262|30|12|602-604

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.12, 2007-11, pp. : 602-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 637-643

Karger

Access to resources Recommend Favorite

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study)

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 634-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver‐limited metastasis

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3649-3658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Reintroduction of Cetuximab in 5 Patients with Advanced, Chemotherapy-Resistant, Colorectal Cancer without Progressive Disease following First-Line Therapy with a Cetuximab-Containing Regimen

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

Pediatric patient with end‐stage kidney disease secondary to Eagle‐Barrett syndrome and metastatic unresectable hepatoblastoma treated successfully with chemotherapy and liver‐kidney transplant

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite